Granite Bio

Bioscience & Disease Healthcare Systems

Website LinkedIn Basel, Switzerland

About Granite Bio

Granite Bio is focused on developing immunology assets, pioneering a new approach to tackling inflammation, autoimmunity, and fibrosis by addressing fundamental disease drivers at their source. The company is developing first-in-class therapeutic antibodies aimed at depleting pathogenic cells.

Business Information

Target Customers

biopharma companies research institutions healthcare providers

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model Biopharmaceutical development

Sales Channels direct sales, partnerships with healthcare providers

Funding Timeline

Round	Date	Amount	Investors
Series B	Apr 24, 2025	$70.0M	Versant Ventures

Founders

No founder information available.

Investors

Versant Ventures

Venture Capital

Recent Mentions

BioWorld @BioWorld

Apr 24, 2025

Versant Ventures newest Swiss startup, Granite Bio, launches with a $70M series B, bringing total raised for two #immunology assets to $100M. https://t.co/wJ9kunwHdP #biopharma #inflammation #ulcerativecolitis #financing

View on Twitter

BioWorld @BioWorld

Apr 25, 2025

View on Twitter

Similar Startups

Longbio

87% match

Longbio Pharma is a biotech startup focused on developing innovative therapies for autoimmune and ra...

Grin Therapeutics

85% match

Grin Therapeutics is a healthcare startup focused on developing innovative therapies to improve pati...

Avammune Therapeutics

85% match

Avammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and de...

Kiin Bio

85% match

Kiin Bio is an AI-powered drug discovery platform that develops virtual scientists to accelerate the...